Financials
Financial year 2025
E-pharma from Antwerpen, company number BE0821059072, closed financial year 2025 with a result of € 108,372 after tax. For that financial year E-pharma recorded a gross margin of € 842,368 and equity of € 497,097. Compared with financial year 2024, the result moved from € -133,408 to € 108,372. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 497,097
▲ 28% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 108,372
▲ still € 133,408 loss in 2024
Profit after tax over the fiscal year.
€ 101,316
▼ 82% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 472,097.
People and assets in 2025
8.8
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 661,617
▲ € 509,471 vs 2024
€ 75,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 2.2 million
▲ 157% vs 2024
€ 77,779 is repaid this year. At this pace the long-term loan is gone in ≈ 28 years.
€ 36,846
▼ 39% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 136,598
▲ 118% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 119,824 | € 66,013 | € 116,608 | € 842,368 | ▲ € 725,759 |
| Profit after taxes | € 52,625 | € -2,350 | € -133,408 | € 108,372 | ▲ € 241,780 |
| Equity | € 1,062,483 | € 1,060,133 | € 388,725 | € 497,097 | ▲ 28% |
| Total debts | € 2,032,082 | € 2,015,637 | € 2,588,902 | € 2,622,628 | ▲ 1% |
| Cash | € 2,625 | - | € 550,349 | € 101,316 | ▼ 82% |
| Land & buildings | € 435,601 | € 417,451 | € 399,300 | € 381,150 | ▼ 5% |
| Retained profit | € 1,037,483 | € 1,035,133 | € 363,725 | € 472,097 | ▲ 30% |
| Dividend | € 0 | € 0 | € 538,000 | € 0 | ▼ 100% |
| Bank debt | € 1,294,120 | € 1,187,774 | € 838,480 | € 2,151,595 | ▲ 157% |
| Balance sheet total | € 3,094,565 | € 3,075,770 | € 2,977,626 | € 3,119,725 | ▲ 5% |
| Employees (FTE) | - | - | 8.3 | 8.8 | ▲ 0.5 |
By gross margin, E-pharma ranks 1st of 10 companies with main activity “Detailhandel in farmaceutische producten” in Antwerpen that publish figures (fiscal year 2025).
Key figures of E-pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about E-pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to E-pharma?
What happened at E-pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 108,372. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 52,625 profit in 2022 to € 108,372 profit in 2025.
Paid € 17,542 in corporate taxes since 2022.
Best year ever: 2025, with € 108,372 profit.
On average € 95,700 of value added per employee in 2025.
Management
The stake of AMBIXX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
E-pharmaBehind E-pharma is Ambixx BV. The shares are held by AMBIXX (100%). It owns 100% of Apotheek Zwaantje, 100% of Apotheek De Voogt and 100% of Apotheek Cauwenbergh itself.
Directors
According to the 2025 annual accounts
Shareholders
100%
Participations
Establishments
Establishment units
Physical locations of this company
Heidestraat 217
2660 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Antwerpen
Same main activity (Detailhandel in farmaceutische producten), 9 active companies in Antwerpen, largest first.
€ 298,420 gross margin · 2025
€ 216,787 gross margin · 2025
€ 205,352 gross margin · 2025
€ 127,073 gross margin · 2025
€ 93,300 gross margin · 2025
€ 40,008 gross margin · 2025
Details
- Company number
- 0821.059.072
- VAT number
- BE 0821.059.072
- Registered office
- Heidestraat 217, 2660 Antwerpen
- Names & denominations
- E-pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 December 2009
- Peppol
- Active · Active since 21 Mar 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings
Overige dienstverlenende activiteiten op het gebied van informatie
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.